166 related articles for article (PubMed ID: 20354780)
21. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
22. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
23. Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells.
Kim H; Kim ND; Lee J; Han G; Sim T
Biochem Biophys Res Commun; 2013 Jul; 437(2):319-24. PubMed ID: 23817042
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
25. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
[TBL] [Abstract][Full Text] [Related]
27. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells.
Tse KW; Lin KB; Dang-Lawson M; Guzman-Perez A; Aspnes GE; Buckbinder L; Gold MR
Cell Immunol; 2012; 275(1-2):47-54. PubMed ID: 22507871
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2.
Vadlamudi RK; Adam L; Nguyen D; Santos M; Kumar R
J Cell Physiol; 2002 Feb; 190(2):189-99. PubMed ID: 11807823
[TBL] [Abstract][Full Text] [Related]
29. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
30. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
31. Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration.
Chalkiadaki G; Nikitovic D; Berdiaki A; Katonis P; Karamanos NK; Tzanakakis GN
IUBMB Life; 2011 Feb; 63(2):109-19. PubMed ID: 21360640
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells.
Earley S; Plopper GE
Biochem Biophys Res Commun; 2008 Feb; 366(2):476-82. PubMed ID: 18073135
[TBL] [Abstract][Full Text] [Related]
33. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
34. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
35. Sodium arsenite exposure alters cell migration, focal adhesion localization and decreases tyrosine phosphorylation of focal adhesion kinase in H9C2 myoblasts.
Yancy SL; Shelden EA; Gilmont RR; Welsh MJ
Toxicol Sci; 2005 Apr; 84(2):278-86. PubMed ID: 15537746
[TBL] [Abstract][Full Text] [Related]
36. Cellular characterization of a novel focal adhesion kinase inhibitor.
Slack-Davis JK; Martin KH; Tilghman RW; Iwanicki M; Ung EJ; Autry C; Luzzio MJ; Cooper B; Kath JC; Roberts WG; Parsons JT
J Biol Chem; 2007 May; 282(20):14845-52. PubMed ID: 17395594
[TBL] [Abstract][Full Text] [Related]
37. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
38. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
39. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
40. Growth factors stimulate kidney proximal tubule cell migration independent of augmented tyrosine phosphorylation of focal adhesion kinase.
Cao Y; Baig MR; Hamm LL; Wu K; Simon EE
Biochem Biophys Res Commun; 2005 Mar; 328(2):560-6. PubMed ID: 15694384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
